| Health & Pharmaceuticals Committee
IPR status in Egypt - January 2000
The committee held meetings on December 12 and 19 both focusing
on the issues of IPR status in Egypt, an analysis of the draft patent
law, social commitments and the image of the industry. The December
19 meeting featured presentations by Dr. Samir Khalil, regional
director for policy & external affairs for Merck USA, and Dr.
Adel Mahmoud, president of the vaccine division of Merck USA.
Top |